Skip to main content

Table 1 Number of drugs and active ingredients among statins*

From: Effective policy initiatives to constrain lipid-lowering drug expenditure growth in South Korea

  Year 2005 2006 2007 2008 2009
Number of drugs Total 183 207 217 227 271
Core medicines (A)   167 192 176 204
Exiting medicines (B)   16 15 41 23
New entrants (C)   40 25 51 67
   - New molecular entities   0 0 0 1
   - New medicines   1 0 1 5
   - New generic medicines   9 13 37 29
   - Others   30 12 13 32
Number of active ingredients Total 19 22 23 24 30
Core medicines (A)   19 22 23 24
Exiting medicines (B)   6 4 8 6
New entrants (C)   13 8 12 17
   - New molecular entities   0 0 0 1
   - New medicines   1 0 1 5
   - New generic medicines   6 5 6 5
     - Others   6 3 5 6
  1. *This table includes only those statins that were prescribed by doctors out of statins on the Korean National Health Insurance benefit list.